JBIO
Jade Biosciences, Inc.
NASDAQ: JBIO · HEALTHCARE · BIOTECHNOLOGY
$24.40
+9.32% today
Updated 2026-04-30
Market cap
$1.32B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.19
Dividend yield
—
52W range
$7 – $28
Volume
0.6M
Jade Biosciences, Inc. (JBIO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-112.7%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+97.6%
Most recent quarter
When is the next earnings report?
Reporting date
December 31, 2025
Consensus EPS estimate
$-0.47
Fiscal period ending
2025-12-31
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.2%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-1.2%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-11-12 | $-0.48 | +28.4% | $9.80 | $9.68 | -1.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.47 | — | — | — | — |
| 2025-09-30 | $-0.67 | $-0.48 | +28.4% | — | — |
| 2025-06-30 | $-0.48 | $-0.86 | -79.2% | — | — |
| 2025-03-31 | $-2.05 | $-12.10 | -490.2% | — | — |
| 2024-12-31 | $-0.40 | $-6.61 | -1542.2% | — | — |
| 2024-09-30 | $-0.58 | $-19.60 | -3274.7% | — | — |
| 2024-06-30 | $-0.85 | $-30.10 | -3441.2% | — | — |
| 2024-03-31 | $-0.76 | $-0.83 | -9.2% | — | — |
| 2023-12-31 | $-0.74 | $-25.90 | -3400.0% | — | — |
| 2023-09-30 | $-0.69 | $-0.71 | -2.9% | — | — |
| 2023-06-30 | $-0.70 | $-0.76 | -8.6% | — | — |
| 2023-03-31 | $-0.57 | $-0.67 | -17.5% | — | — |
Frequently asked questions
When does Jade Biosciences, Inc. report next earnings?
Jade Biosciences, Inc. (JBIO) is scheduled to report earnings on December 31, 2025. The consensus EPS estimate is $-0.47.
Has Jade Biosciences, Inc. beaten earnings estimates?
Jade Biosciences, Inc. has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -112.7% over the last 4 quarters.
How does JBIO stock react to earnings?
JBIO stock has moved an average of -1.2% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.